SCHEMBL4601900

SCHEMBL4601900

CC(C)[Si](OCCOc1ccc(CCC(=O)O)c(Oc2ncc(C(F)(F)F)cc2Cl)c1)(C(C)C)C(C)C

nearest known ligand 0.60

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARG P37231 17/20 0.60
SMN1; SMN2 Q16637 1/20 0.50
FFAR1 O14842 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3207531 0.90 PPARG (0.56) PPARG
SCHEMBL3217520 0.88 PPARG (0.73) PPARGSMN1; SMN2
SCHEMBL3207856 0.88 PPARG (0.57) PPARG
SCHEMBL3205204 0.86 PPARG (0.72) PPARGSMN1; SMN2FFAR1
SCHEMBL3206453 0.86 PPARG (0.71) PPARGSMN1; SMN2
SCHEMBL3207082 0.84 PPARG (0.72) PPARGSMN1; SMN2
SCHEMBL3214072 0.82 PPARG (0.57) PPARGSMN1; SMN2FFAR1
SCHEMBL3214082 0.82 PPARG (0.57) PPARGSMN1; SMN2FFAR1
SCHEMBL3206768 0.82 PPARG (0.72) PPARGSMN1; SMN2FFAR1
SCHEMBL4601009 0.80 SMN1; SMN2 (0.54) PPARGSMN1; SMN2FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912645-A2 THERAPEUTIC AGENT FOR DIABETES Takeda Pharmaceutical Company Limited (JP) 2008-04-23 EP disclosed
WO-2007018314-A2 THERAPEUTIC AGENT FOR DIABETES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-02-15 WO disclosed